TowerView LLC’s Corvus Pharmaceuticals CRVS Stock Holding History

TowerView LLC’s Portfolio CRVS Stock Details CRVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$680K	Buy
2025 Q1	$405K	Buy
2024 Q4	$415K	Sell
2024 Q3	$620K	Sell
2024 Q2	$728K	Buy
2024 Q1	$681K	Sell
2023 Q4	$769K	Buy
2023 Q3	$500K	Buy
2023 Q2	$469K	Buy